do glp 1 cause migraines Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain Glucagon-like peptide-1 (GLP-1) receptor agonists

Low GSH, neutrophil infiltration, myeloperoxidase activity and inflammation increase oxidative stress overwhelming the antioxidant defense, and hypochlorous acid mediated GSH oxidation and its attachment to proteins contribute to further GSH deficiency (114)

Screening will be particularly important for people who are considered overweight, since their restrictive or disordered eating habits are already often overlooked because their weight doesnt reflect the typical look of the disorder

In fact, liraglutide (1.8 mg daily) and semaglutide (0.5 mg weekly) both significantly outperformed dulaglutide (1.5 mg weekly) for weight loss in head-to-head trials at doses that induce comparable HbA1c lowering (13, 22)

Gandasi NR, Yin P, Omar-Hmeadi M, Ottosson Laakso E, Vikman P, Barg S (2018) Glucose-dependent granule docking limits insulin secretion and is decreased in human type 2 diabetes

Its important to note that ALC crosses the blood brain barrier which means it has access to the brain and can influence brain activity

doi:10.1186/s13229-016-0088-6 7